Categories
Cancer Medicine Surgery

Immediate reconstruction after breast cancer: A most disturbing study

I realize that being in academic medicine at a tertiary care center often produces the “ivory tower” syndrome, but occasionally it is brought home to me that the way we practice surgery here often differs considerably from how surgery is practiced “in the trenches.” This time around, it was a study about how often surgeons […]

Categories
Cancer Complementary and alternative medicine Medicine

Alternative medicine and breast cancer

After the three posts that I recently did about vaccination have garnered well over 250 comments between the three of them (and still counting), I thought it might be time to switch topics. As important as they are, I don’t want this blog to become all vaccines all the time. (After all, look what happened […]

Categories
Clinical trials Medicine Politics

No, “right-to-try” has not “saved thousands of lives,” contrary to Donald Trump’s claims

Former President Donald Trump bragged in his acceptance speech at the Republican National Convention that “right-to-try” had saved “thousands of lives”? I realize that his speech seems like ancient history now, but I still had to ask: What’s the real story?

Categories
Cancer Medicine Naturopathy

Pediatric naturopathic oncology: A horrifying concept

“Naturopathic oncology” is a specialty made up by naturopaths in order to justify using their quackery to treat cancer patients. A new survey takes it a step further and looks at using naturopathy to treat children with cancer, including the use of homeopathy, reiki, and restrictive diets.

Categories
Medicine Politics Popular culture

“Right-to-try” in 2019: Still a failure, still all about the Benjamins (and weakening the FDA)

Federal “right-to-try” legislation was passed and signed into law by President Trump over a year ago. Advocates promised that lots of terminally ill people who were dying then would be saved by having the right to “try” experimental therapies outside of the context of clinical trials. That has not happened. This should come as no surprise, because right-to-try was never about getting experimental drugs to dying patients. It was always about weakening the FDA and making money.